J4 ›› 2012, Vol. 38 ›› Issue (1): 93-95.

• 技术交流 • 上一篇    下一篇

TGFβ1/Smads信号通路相关蛋白在乳腺癌组织中的表达及其临床意义

孙凤丹1|张金子1,2|崔 演3|程志芬1|代 博2|玄延花1   

  1. 1.延边大学基础医学院病理学教研部|吉林 延吉133002;2.吉林博华医院内科|吉林 吉林 132013;3.延边大学附属医院肿瘤科|吉林 延吉 133000
  • 收稿日期:2011-10-10 出版日期:2012-01-28 发布日期:2012-01-13
  • 通讯作者: 玄延花(Tel: 0433-2435059,E-mail:xuanyh1@ybu.edu.cn) E-mail:xuanyh1@ybu.edu.cn
  • 作者简介:孙凤丹(1964-)|女|吉林省九台市人|副教授|医学硕士|主要从事肿瘤病理学研究。
  • 基金资助:

    国家自然科学基金资助课题(30560047,81160315)

Expressions of TGFβ1/Smads proteins in breast cancer tissues and their clinical significances

SUN Feng-dan1,ZHANG Jin-zi1|2|CUI Yan3,CHENG Zhi-fen1|DAI Bo2,XUAN Yan-hua1   

  1. 1.Department of Pathology|School of Basic |Medicine|Yanbian University,Yanji 133002| China; 2.Department of Medicine|Jilin Bohua Hospital|Jilin 132013|China;3.Department of Oncology,Affiliated Hospital,Yanbian University,Yanji 133000|China
  • Received:2011-10-10 Online:2012-01-28 Published:2012-01-13

摘要:

目的:研究TGFβ1/Smads信号通路相关蛋白在乳腺癌组织中的表达,阐明其与乳腺癌临床病理学特征的关系。方法:采用免疫组化EnVision方法检测121例乳腺导管癌和21例正常乳腺导管上皮组织芯片中TGFβ1、TGFβRⅠ、 TGFβRⅡ、Smad2/3和Smad4蛋白的表达水平,分析其与乳腺癌临床病理学特征的关联性。结果:免疫组化染色,TGFβ1、TGFβRⅠ、Smad2/3和TGFβRⅡ在乳腺癌组织均呈高表达,Smad4在乳腺癌组织表达水平明显低于正常导管上皮中的表达水平(P<0.01);≤55岁乳腺癌患者TGFβ1表达水平明显高于>55岁患者(P<0.05);孕激素受体(PR)阴性乳腺癌患者TGFβ1表达水平明显高于PR阳性患者(P<0.05),未发生淋巴结转移乳腺癌患者TGFβ1、TGFβRⅠ和TGFβ RⅡ的表达水平明显高于淋巴结转移患者(P<0.05或P<0.01);不同临床分期乳腺癌患者TGFβRⅡ和Smad2/3表达水平具有明显差异,Ⅱa、Ⅱb和Ⅲa期乳腺癌患者TGFβRⅡ表达水平明显低于0期(P<0.01),Ⅰ期和Ⅱb期乳腺癌患者Smad2/3表达明显低于在0期(P<0.01)。TGFβ1表达水平分别与TGFβRⅠ和TGFβRⅡ表达水平呈正相关关系(r=0.46,P<0.01;r=0.44,P<0.01)。结论:TGFβ1/Smads信号通路相关蛋白的高表达可以作为乳腺癌的辅助诊断指标,提示TGFβ1/Smads信号通路相关蛋白检测可作为判定乳腺癌预后的指标。

关键词:  TGFβ1/Smads;乳腺肿瘤;免疫组织化学

Abstract:

Abstract:Objective To investigate the expressions of TGFβ1/Smads signaling pathway proteins in breast cancer tissues and clarify their  relationship with the clinicopathological characteristics of breast cancer. Methods The expressions of TGFβ
1,TGFβRⅠ,TGFβRⅡ,Smad2/3 and Smad4 proteins in 121 cases of breast ductal carcinoma and 21 cases of normal breast ductal epithelium tissues were detected in tissue microarray by immunohistochemistry EnVision method,and the relationship between their expressions and clinicopathological characteristics of breast cancer was analyzed. Results The immunohistochemical staining results showed that the expressions of TGFβ1,TGFβRⅠ,TGFβRⅡ and Smad2/3 in breast cancer tissues were higher;and the expression of Smad4 in breast cancer  tissues was lower than that in normal ductal epithelium tissue(P<0.01). The expression level of TGFβ1 in less than 55 years of age patients was significantly higher than that in over 55 years of patients(P<0.05);and the TGFβ1 expression in patients with breast cancer in PR negative group was significantly higher than that in positive group(P<0.05). The expressions of TGFβ1,TGFβRⅠ and TGFβRⅡ in patients without lymph node metastasis were significantly higher than those in patients with metastasis(P<0.05 or P<0.01). The expressions of TGFβRⅡ and Smad2/3 had significant differences between patients with different clinical stages. The expressions of TGFβRⅡ in the patients with breast cancer in stage Ⅱa,Ⅱb and Ⅲa  were lower than that in stage 0 (P<0.01).The Smad2/3 expression in the patients with breast cancer in stageⅠ and Ⅱb  were lower than that in stage 0(P<0.01). The expression of TGFβ1 was positively correlated to the expressions of TGFβRⅠand TGFβRⅡ(r=0.46,P<0.01;r=0.44,P<0.01). Conclusion High expression of TGFβ1/Smads proteins might be helpful markers for the diagnosis of breast cancer.It indicates that TGFβ1/S
mads proteins  can be used as indicators in judging the prognosis of breast cancer.

Key words:  TGFβ1/Smads;breast neoplasms;immunohistochemistry

中图分类号: 

  •